Literature DB >> 23101464

Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states.

Victor M Karpyak1, Stacey J Winham, Ulrich W Preuss, Peter Zill, Julie M Cunningham, Denise L Walker, Kriste A Lewis, Jennifer R Geske, Colin L Colby, Osama A Abulseoud, Daniel K Hall-Flavin, Larissa L Loukianova, Terry D Schneekloth, Mark A Frye, Igor Bazov, John A Heit, Georgy Bakalkin, David A Mrazek, Joanna M Biernacka.   

Abstract

Synthetic κ-opioid receptor (KOR) agonists induce dysphoric and pro-depressive effects and variations in the KOR (OPRK1) and prodynorphin (PDYN) genes have been shown to be associated with alcohol dependence. We genotyped 23 single nucleotide polymorphisms (SNPs) in the PDYN and OPRK1 genes in 816 alcohol-dependent subjects and investigated their association with: (1) negative craving measured by a subscale of the Inventory of Drug Taking Situations; (2) a self-reported history of depression; (3) the intensity of depressive symptoms measured by the Beck Depression Inventory-II. In addition, 13 of the 23 PDYN and OPRK1 SNPs, which were previously genotyped in a set of 1248 controls, were used to evaluate association with alcohol dependence. SNP and haplotype tests of association were performed. Analysis of a haplotype spanning the PDYN gene (rs6045784, rs910080, rs2235751, rs2281285) revealed significant association with alcohol dependence (p = 0.00079) and with negative craving (p = 0.0499). A candidate haplotype containing the PDYN rs2281285-rs1997794 SNPs that was previously associated with alcohol dependence was also associated with negative craving (p = 0.024) and alcohol dependence (p = 0.0008) in this study. A trend for association between depression severity and PDYN variation was detected. No associations of OPRK1 gene variation with alcohol dependence or other studied phenotypes were found. These findings support the hypothesis that sequence variation in the PDYN gene contributes to both alcohol dependence and the induction of negative craving in alcohol-dependent subjects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23101464      PMCID: PMC3901318          DOI: 10.1017/S1461145712001137

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  46 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Exploratory findings from the Reasons for Drinking Questionnaire.

Authors:  William H Zywiak; Verner S Westerberg; Gerard J Connors; Stephen A Maisto
Journal:  J Subst Abuse Treat       Date:  2003-12

3.  Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect.

Authors:  Samuel S Newton; Johannes Thome; Tanya L Wallace; Yukihikko Shirayama; Lee Schlesinger; Norio Sakai; Jingshan Chen; Rachael Neve; Eric J Nestler; Ronald S Duman
Journal:  J Neurosci       Date:  2002-12-15       Impact factor: 6.167

4.  Psychotomimesis mediated by kappa opiate receptors.

Authors:  A Pfeiffer; V Brantl; A Herz; H M Emrich
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

5.  Localization of kappa-opioid receptor mRNA in neuronal subpopulations of rat sensory ganglia and spinal cord.

Authors:  M K Schäfer; M Bette; H Romeo; W Schwaeble; E Weihe
Journal:  Neurosci Lett       Date:  1994-02-14       Impact factor: 3.046

6.  Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.

Authors:  Stephen D Mague; Andrea M Pliakas; Mark S Todtenkopf; Hilarie C Tomasiewicz; Yan Zhang; William C Stevens; Robert M Jones; Philip S Portoghese; William A Carlezon
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

Review 7.  A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist.

Authors:  M-L G Wadenberg
Journal:  CNS Drug Rev       Date:  2003

8.  Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects.

Authors:  Yukihiko Shirayama; Hisahito Ishida; Masaaki Iwata; Gen-I Hazama; Ryuzou Kawahara; Ronald S Duman
Journal:  J Neurochem       Date:  2004-09       Impact factor: 5.372

9.  Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.

Authors:  Mark S Todtenkopf; Jacqueline F Marcus; Philip S Portoghese; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2004-01-16       Impact factor: 4.530

10.  Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence.

Authors:  Tanya J Williams; K Steven LaForge; Derek Gordon; Gavin Bart; Scott Kellogg; Jurg Ott; Mary Jeanne Kreek
Journal:  Addict Biol       Date:  2007-06-08       Impact factor: 4.280

View more
  17 in total

Review 1.  Genetic studies of alcohol dependence in the context of the addiction cycle.

Authors:  Matthew T Reilly; Antonio Noronha; David Goldman; George F Koob
Journal:  Neuropharmacology       Date:  2017-01-22       Impact factor: 5.250

Review 2.  Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

Authors:  Rachel I Anderson; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-06-05       Impact factor: 3.455

Review 3.  Emerging Role of Epigenetic Mechanisms in Alcohol Addiction.

Authors:  Tiffani D M Berkel; Subhash C Pandey
Journal:  Alcohol Clin Exp Res       Date:  2017-02-18       Impact factor: 3.455

4.  Association of Alcohol Use Disorder Risk With ADH1B, DRD2, FAAH, SLC39A8, GCKR, and PDYN Genetic Polymorphisms.

Authors:  Evangelia Legaki; Domna Tsaklakidou; Alex Hatzimanolis; Eirini Segredou; Markos Petalotis; Giannoula Moularogiorgou; Varvara Mouchtouri; Lefteris Lykouras; Nikos C Stefanis; Maria Gazouli
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

5.  Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.

Authors:  Chloe M Erikson; Gengze Wei; Brendan M Walker
Journal:  Neuropharmacology       Date:  2018-07-31       Impact factor: 5.250

6.  κ-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites.

Authors:  Maenghee Kang-Park; Brigitte L Kieffer; Amanda J Roberts; George R Siggins; Scott D Moore
Journal:  J Pharmacol Exp Ther       Date:  2013-04-15       Impact factor: 4.030

7.  Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression.

Authors:  Sarah Ann R Anderson; Michael Michaelides; Parisa Zarnegar; Yanhua Ren; Pernilla Fagergren; Panayotis K Thanos; Gene-Jack Wang; Michael Bannon; John F Neumaier; Eva Keller; Nora D Volkow; Yasmin L Hurd
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

8.  Asymmetry of the endogenous opioid system in the human anterior cingulate: a putative molecular basis for lateralization of emotions and pain.

Authors:  Hiroyuki Watanabe; Sylvia Fitting; Muhammad Z Hussain; Olga Kononenko; Anna Iatsyshyna; Takashi Yoshitake; Jan Kehr; Kanar Alkass; Henrik Druid; Henrik Wadensten; Per E Andren; Ingrid Nylander; Douglas H Wedell; Oleg Krishtal; Kurt F Hauser; Fred Nyberg; Victor M Karpyak; Tatjana Yakovleva; Georgy Bakalkin
Journal:  Cereb Cortex       Date:  2013-08-19       Impact factor: 5.357

9.  PNPLA3 Association with Alcoholic Liver Disease in a Cohort of Heavy Drinkers.

Authors:  Bhanu Prakash Kolla; Terry D Schneekloth; Joanna Biernacka; Vijay Shah; Konstantinos N Lazaridis; Jennifer Geske; Victor Karpyak
Journal:  Alcohol Alcohol       Date:  2018-07-01       Impact factor: 2.826

Review 10.  Epigenetic and Transcriptional Control of the Opioid Prodynorphine Gene: In-Depth Analysis in the Human Brain.

Authors:  Olga Nosova; Igor Bazov; Victor Karpyak; Mathias Hallberg; Georgy Bakalkin
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.